Texas
LATEST FROM BIOSPACE
These days, when someone mentions blood-testing diagnostics systems that rely on a few drops of blood, first thoughts may head directly to the alleged fraud committed by the founder and chief executive officer of Theranos, Elizabeth Holmes. But despite that background, the co-founders of Microdrop believe they have a blood-testing diagnostics system that will bring levels of confidence back to the space due to validation from the scientific community.
Alcon CEO says the company is “poised to achieve sustainable growth and create long-term shareholder value as a standalone company.”
The recent CBRE Research report, “2019 U.S. Life Sciences Clusters” has two Texas metropolitan areas in its top-10 fastest-growing life sciences market. Houston ranked third, while Dallas/Ft. Worth ranked seventh. Let’s look at Dallas/Ft. Worth.
Public perception of the industry can be a bit confusing. Life Science Leader recently pulled together several biopharma executives for a round table discussion of the biopharma industry’s public perception—generally bad—and what might be able to do about it.
A recent report by CBRE Research analyzing U.S. life science clusters, found that Houston, Texas is the third-fastest growing life science market from 2014 to 2017. One doesn’t typically think of Texas, let alone Houston, as being a center for the life sciences. Oil, energy and tech, yes, but not life sciences.
The American Association for Cancer Research (AACR) Annual Meeting is taking place in Atlanta. Here’s a look at just a few stories coming out of the meeting.
The vast majority of Americans are happy at their jobs, according to a new survey conducted by CNBC and Survey Monkey. A BioSpace poll shows that a lot of people in the life sciences industries are not happy at work.
According to a recent BioSpace survey, 69% of employers indicated “finding quality talent” will be a significant challenge in 2019. Are you the quality talent life science employers are looking for? Don’t delay, apply now and show these employers you possess the quality skills they need!
Gottlieb said the FDA believes there should be a premarket demonstration that a new opioid is superior to an already-approved opioid.
A recent study conducted by 24/7 Wall St. looked at data from the BLS and OES databases for 2017 to identify the cities with the highest percentage of STEM-intensive jobs.
PRESS RELEASES